Shimomura Kazunori, Moriguchi Yu, Nansai Ryosuke, Fujie Hiromichi, Ando Wataru, Horibe Shuji, Hart David A, Gobbi Alberto, Yoshikawa Hideki, Nakamura Norimasa
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Biomechanics Laboratory, Department of Mechanical Engineering, Kogakuin University, Tokyo, Japan.
Am J Sports Med. 2017 Mar;45(3):666-675. doi: 10.1177/0363546516668835. Epub 2016 Oct 23.
Previously, we developed a hybrid implant composed of hydroxyapatite (HA)-based artificial bone coupled with a mesenchymal stem cell (MSC)-based scaffold-free tissue-engineered construct (TEC) and demonstrated its feasibility for osteochondral repair. Beta-tricalcium phosphate (βTCP) may be a promising alternative to HA, as it is a highly biocompatible material and is resorbed more rapidly than HA in vivo.
A βTCP-based hybrid TEC implant will exhibit superior osteochondral repair when directly compared with an HA-based hybrid implant, as tested using a rabbit osteochondral defect model.
Controlled laboratory study.
Osteochondral defects were created in the femoral groove of skeletally mature rabbits. The TEC and artificial bone, using either HA or βTCP with the same porosities and similar mechanical properties, were hybridized and then implanted in the defects. A histological evaluation and microindentation testing were performed for the assessment of repair tissue.
Osteochondral defects treated with the TEC/βTCP implants showed more rapid subchondral bone repair at 1 month, but the cartilaginous tissue deteriorated over time out to 6 months after implantation. Osteochondral defects treated with the TEC/HA implants maintained good histological quality out to 6 months after implantation and also exhibited better biomechanical properties at 6 months as compared with the TEC/βTCP implants.
Contrary to our hypothesis, the TEC/HA hybrid implant facilitated better osteochondral repair than did the TEC/βTCP implant. The results of the present study suggest the importance of a stable restoration of subchondral bone for long-term effective osteochondral repair rather than rapid remodeling of subchondral bone.
This study contributes to the future selection of suitable materials for patients with osteochondral lesions.
此前,我们研发了一种混合植入物,它由羟基磷灰石(HA)基人工骨与基于间充质干细胞(MSC)的无支架组织工程构建体(TEC)组成,并证明了其用于骨软骨修复的可行性。β-磷酸三钙(βTCP)可能是HA的一种有前景的替代品,因为它是一种高度生物相容性材料,且在体内比HA吸收更快。
与基于HA的混合植入物直接比较时,基于βTCP的混合TEC植入物在使用兔骨软骨缺损模型测试时将表现出更好的骨软骨修复效果。
对照实验室研究。
在骨骼成熟的兔股骨沟中制造骨软骨缺损。将具有相同孔隙率和相似力学性能的使用HA或βTCP的TEC和人工骨进行混合,然后植入缺损处。进行组织学评估和微压痕测试以评估修复组织。
用TEC/βTCP植入物治疗的骨软骨缺损在1个月时显示出更快的软骨下骨修复,但软骨组织在植入后6个月内随时间恶化。用TEC/HA植入物治疗的骨软骨缺损在植入后6个月内保持良好的组织学质量,并且与TEC/βTCP植入物相比,在6个月时还表现出更好的生物力学性能。
与我们的假设相反,TEC/HA混合植入物比TEC/βTCP植入物促进了更好的骨软骨修复。本研究结果表明,对于长期有效的骨软骨修复,稳定恢复软骨下骨比快速重塑软骨下骨更重要。
本研究有助于未来为骨软骨损伤患者选择合适的材料。